BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 7682814)

  • 1. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
    Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
    Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
    Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
    J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.
    Chien DY; Choo QL; Tabrizi A; Kuo C; McFarland J; Berger K; Lee C; Shuster JR; Nguyen T; Moyer DL
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10011-5. PubMed ID: 1279666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
    Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
    J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection.
    Sansonno D; Dammacco F
    Hepatology; 1993 Aug; 18(2):240-5. PubMed ID: 8340053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease.
    Brown J; Dourakis S; Karayiannis P; Goldin R; Chiba J; Ohba H; Miyamura T; Thomas HC
    Hepatology; 1992 Feb; 15(2):175-9. PubMed ID: 1370945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome.
    Hiramatsu N; Hayashi N; Haruna Y; Kasahara A; Fusamoto H; Mori C; Fuke I; Okayama H; Kamada T
    Hepatology; 1992 Aug; 16(2):306-11. PubMed ID: 1379209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of an anti-HCV core peptide ELISA.
    Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
    J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
    Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
    Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
    Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
    Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
    Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus replication and antibodies to structural and nonstructural viral proteins in chronic hepatitis C.
    Yuki N; Hayashi N; Hagiwara H; Naito M; Kasahara A; Fusamoto H; Kamada T
    J Hepatol; 1994 Mar; 20(3):421-5. PubMed ID: 7516952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
    Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
    Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
    Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
    J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.